KP Tissue Cash Flow Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2014
Net Income	6.87	-4.94	-10.25	1.24	-1.95	-6.53	Upgrade
Loss (Gain) From Sale of Investments	0.13	0.13	4.46	5	-0.63	-0.57	Upgrade
Loss (Gain) on Equity Investments	-7.21	0.7	8.09	-6.13	1.43	5.38	Upgrade
Other Operating Activities	0.01	3.82	-2.22	-0.35	1.01	1.54	Upgrade
Change in Accounts Receivable	-	-	-	0.02	0.15	0.02	Upgrade
Change in Accounts Payable	0.2	0.29	-0.08	0.21	-	-	Upgrade
Investment in Securities	-	-	6.62	5.56	5.6	4.98	Upgrade
Other Investing Activities	6.99	6.98	-	-	-	-	Upgrade
Investing Cash Flow	6.99	6.98	6.62	5.56	5.6	4.98	Upgrade
Dividends Paid	-6.99	-6.98	-6.62	-5.56	-5.6	-4.98	Upgrade
Financing Cash Flow	-6.99	-6.98	-6.62	-5.56	-5.6	-4.98	Upgrade
Cash Income Tax Paid (Refunded)	0.2	0.29	-0.08	2.28	1.02	-	Upgrade
Change in Net Working Capital	-0.35	-0.22	2.46	0.52	-1.8	-1.28	Upgrade

Source: S&P Capital IQ. Standard template.